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The apicomplexan parasite Cryptosporidium parvum contains an expanded
family of 22 insulinase-like proteases (INS), a feature that contrasts with their otherwise
streamlined genome. Here, we examined the function of INS1, which is most similar to
the human insulinase protease that cleaves a variety of small peptide substrates. INS1 is
an M16A clan member and contains a signal peptide, an N-terminal domain with the
HXXEH active site, followed by three inactive domains. Unlike previously studied C. parvum INS proteins that are expressed in sporozoites and during merogony, INS1 was
expressed exclusively in macrogamonts, where it was localized in small cytoplasmic
vesicles. Although INS1 did not colocalize with the oocyst wall protein recognized by
the antibody OW50, immune-electron microscopy indicated that INS1 resides in small
vesicles in the secretory system. Notably, these small INS1-positive vesicles were often in
close proximity to large OW50-positive vacuoles resembling wall-forming bodies, which
contain precursors for oocyst wall formation. Genetic deletion of INS1, or replacement
with an active-site mutant, resulted in lower formation of macrogamonts in vitro and
reduced oocyst shedding in vivo. Our ﬁndings reveal that INS1 functions in the formation or maturation of macrogamonts and that its loss results in attenuated virulence in
immunocompromised mice.

IMPORTANCE Cryptosporidiosis is a debilitating diarrheal disease in young children in
developing countries. The absence of effective treatments or vaccines makes this
infection very difﬁcult to manage in susceptible populations. Although the oral dose
of oocysts needed to cause infection is low, infected individuals shed very high numbers of oocysts, readily contaminating the environment. Our studies demonstrate
that the protease INS1 is important for formation of female sexual stages and that in
its absence, parasites produce fewer oocysts and are attenuated in immunocompromised mice. These ﬁndings suggest that mutants lacking INS1, or related proteases,
are useful for further characterizing the pathway that leads to macrogamont maturation and oocyst wall formation.
KEYWORDS CRISPR/Cas9, active-site mutant, cryptosporidiosis, oocyst shedding,

pathogenesis, sexual development

C

ryptosporidium spp. are apicomplexan parasites that cause diarrheal disease
in humans and animals. Human infection is primarily caused by two species,
Cryptosporidium parvum, which also infects agricultural ruminant animals and is zoonotic, and C. hominis, which is spread human to human (1). Cryptosporidiosis was recognized as one of the top three causes of severe diarrhea in children younger than 2 years of
age in developing countries, as reported by the Global Enteric Multi-Center Study (2).
Infection in early life is also associated with lasting defects in development even after
infections subside (3). Nitazoxanide is the only FDA-approved drug for the treatment of
cryptosporidiosis. However, it has a limited effect in immunocompromised individuals and
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is not approved for use in children under the age of two (4). There are currently no effective vaccines for C. parvum, and fundamental studies on parasite biology and host-pathogen interactions are needed to identify potential therapeutic and vaccine targets.
The entire life cycle of Cryptosporidium occurs in a single host, leading to efﬁcient
fecal-oral transmission (5). Following the ingestion of oocysts, sporozoites emerge and
invade intestinal epithelial cells, where they develop in a unique vacuole formed at the
apex of the host cell (6). The parasite initially grows as a trophozoite before undergoing multiple rounds of asexual replication during merogony (7, 8). The parasite then
differentiates to the sexual phase and develops as macrogamonts or microgamonts
that begin appearing after 44 to 48 h postinfection (hpi) (7, 8). However, in transformed
cell lines grown in vitro, the infection does not progress and parasite numbers gradually decline (9). Comparison of in vitro cultures in adenocarcinoma cell lines to the developmental process that occurs in the intestine of mice revealed that the block to
complete development in vitro is due to a lack of fertilization despite the fact that both
gametocyte forms develop normally (7).
Biological investigations of Cryptosporidium have been hampered by limitations in
experimental platforms for in vitro growth. Despite this limitation, in vitro propagation
systems have been used to generate antibodies that identify different stages of C. parvum (10), leading to a better understanding the life cycle (8). Recent developments
have also provided systems that allow complete development of infectious oocysts in
stem cell-derived cultures in vitro (11, 12). Finally, advances in CRISPR/Cas9 technology
have allowed genetic modiﬁcation in C. parvum to tag genes for localization and disrupt them to study function (13). Despite these advances, we lack an understanding of
the function of most genes in Cryptosporidium, many of which have no orthologues
outside the genus or are speciﬁc for the phylum Apicomplexa (14, 15).
The genome of C. parvum is highly streamlined, with short intergenic regions, limited introns, and the loss of many metabolic pathways (16). Greater than 98% of genes
in C. parvum are present as a single copy, and only a limited number of multigene families include insulinase-like proteases (INS), predicted secretory proteins containing the
amino acid sequence MEDLE, and mucin-type glycoproteins (17). INS proteins belong
to the M16 family of metallopeptidases that play diverse roles in cells, and they can be
found in the cytosol, organelles, and even the cell surface (18). M16 metalloproteases
typically bind zinc as part of their active site (HXXEH), and they cleave short polypeptides, the size of which is constrained by a conserved small barrel fold that forms the
catalytic chamber (19). The apicomplexan parasite Toxoplasma gondii contains ;50
metalloproteases, including 11 members of the M16 clan (20), several of which are
found in secretory organelles implicated in host cell interactions (21, 22). In Plasmodium
falciparum, the M16 metalloprotease falcilysin participates in both hemoglobin degradation and the processing of transit peptides for apicoplast proteins (23, 24). Similarly, other
M16 family members are known for their roles in processing transit peptides for mitochondria and chloroplasts (18).
The C. parvum genome contains 22 members of the M16 family of metallopeptidases. Ten of these contain the active site HXXEH, indicating they act as enzymes in
the parasite, although none of their substrates have been deﬁned. Previous studies
have shown that antibodies against INS20-19 (although originally annotated as two
genes, later assemblies collapsed these into a single gene), INS15, or INS5 inhibit parasite invasion of host cells in vitro, suggesting they are involved in processing substrates
important for host cell recognition or entry (25–27). In the present study, we focused
on INS1, which is present among all Cryptosporidium spp. INS1 is a classic M16A family
member with one active functional motif, HXXEH, followed by three inactive domains.
We demonstrate that INS1 is expressed exclusively in macrogamonts of C. parvum,
where it localizes to small transport vesicles. Deletion of INS1, or replacement with an
inactive-site mutant, reduced formation of macrogamonts in vitro and reduced oocyst
shedding and decreased virulence in immunocompromised mice.
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RESULTS
Epitope tagging of C. parvum INS1. We compared the sequences of the 22 members of the M16 metalloprotease family present in C. parvum using a neighbor-joining
phylogenetic analysis. For comparison, we also included the human insulinase gene
IDE (P14735). Phylogenetic analysis indicated that INS1, encoded by the cgd1_1680
gene, is most similar to IDE (Fig. 1A). INS1 contains a signal peptide and has four
domains, one active domain containing the zinc-binding motif HLIEH and three inactive domains, consistent with INS1 belonging to the M16A clan (Fig. 1B). To investigate
the cellular localization of INS1, we used CRISPR/Cas9 genome editing to tag INS1 with
a triple hemagglutinin (3HA) epitope tag at the C terminus. The tagging construct also
contained a selection cassette consisting of nanoluciferase (Nluc) cotranscribed with
neomycin resistance (Neor) driven by an enolase promoter (13) (Fig. 1C). Similar to
methods described previously, the Nluc and Neo proteins were separated by a split
peptide motif (P2A) (12). This tagging construct was cotransfected with a CRISPR/Cas9
plasmid containing a single guide RNA sequence (sgRNA) located in the C terminus of
the gene. To create parasites with INS1 fused to green ﬂuorescent protein (GFP), we
replaced the 3HA tag with GFP and used the same INS1 sgRNA plasmid (Fig. 1D).
Generation of stable transgenic INS1 parasites. Excysted sporozoites were electroporated with INS1-3HA-Nluc-P2A-neo tagging plasmid and CRISPR/Cas9 plasmid
containing the INS1 sgRNA. Following electroporation, sporozoites were used to infect
Ifngr12/2 mice. Oocyst shedding reached a peak level 13 days postinfection (dpi), and
all of the mice succumbed to infection by day 15, indicating the tagged line was not
attenuated (see Fig. S1 in the supplemental material). Feces were collected from the
ﬁrst round of mice, and a slurry was gavaged into a group of Nod scid gamma (NSG)
mice to obtain the larger numbers of transgenic oocysts for puriﬁcation. All mice were
treated with 16 g/liter paromomycin in drinking water for selection of stable transgenic
parasites (Fig. 2A), as described previously (13). The signal of luminescence from the
nLuc gene increased in fecal pellets from 6 dpi (days postinfection), with a peak value
on 12 dpi (Fig. 2C). Quantiﬁcation of oocysts in feces by qPCR paralleled the increase in
luciferase activity (Fig. 2D). PCR analysis of oocysts collected from the mice conﬁrmed
that the INS1-3HA tagging cassette had correctly inserted into the INS1 locus, as shown
using diagnostic primers that only amplify from the correct transgenic arrangement
(Fig. 2B and E). To obtain a tagged INS1-GFP strain, we used the same strategy to
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FIG 1 Insulinase-like proteases in Cryptosporidium parvum and construction of C. parvum INS1-3HA and INS1-GFP strains. (A) Phylogenetic relationship of C.
parvum insulinase-like protease family and human insulinase. The tree was constructed by a maximum likelihood analysis with 1,000 replications for
bootstrapping. The active site HXXEH in each INS was deﬁned by multiple alignments. The black dot indicates proteins with a predicted active site.
Scale, 50 changes per 100 residues. (B) Domain architecture of INS1 showing the presence of one M16 active domain containing the active site HLIEH and
three inactive domains. (C) Diagram of INS1-3HA tagging strategy. Construct was designed to add a 3HA tag and Nluc-P2A-NeoR cassette at the C terminus
of INS1 (cgd1_1680). P2A, split peptide. INS1 gRNA marks the site of guide RNA homology. (D) Diagram of INS1-GFP tagging strategy. Construct was
designed to add a GFP tag and Nluc-P2A-NeoR cassette at the C terminus of INS1 (cgd1_1680). P2A, split peptide; INS1 gRNA, site of guide RNA homology.
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FIG 2 Ampliﬁcation of transgenic parasites in immunocompromised mice. (A) Ampliﬁcation strategy for obtaining tagged INS1 parasites. Approximately
5  107 sporozoites were cotransfected with 50 m g tagging plasmid and 30 m g CRISPR/Cas9 plasmid per cuvette. Each Ifngr12/2 mouse was gavaged with
200 m l 8% sodium bicarbonate solution 5 min before being infected by gavaged with 2.5  107 transfected sporozoites in 100 m l of DPBS. A second round
of selection was conducted in NSG mice. Each mouse was gavaged with fecal slurry containing 2  104 oocysts obtained at 13 dpi from the ﬁrst round of
selection. All mice received 16 g/liter paromomycin drinking water from the ﬁrst day postinfection (dpi) for the duration of the experiment. (B) Diagram of
the INS1-3HA-tagged locus in stable transgenic parasites. C. parvum was cotransfected with INS1-3HA-Nluc-P2A-neo tagging plasmid and CRISPR/Cas9
plasmid containing an INS1 sgRNA speciﬁc to the INS1 locus. (C) Relative luminescence per milligram of feces from transgenic C. parvum oocysts. Each data
point represents a single pellet, and each connecting line represents an individual infected NSG mouse from round two ampliﬁcation of transfected
parasites. (D) The number of oocysts per milligram of feces was measured by qPCR. Each data point represents a single pellet, and each connecting line
represents an individual NSG mouse from round two of ampliﬁcation of transfected parasites. (E) PCR analysis of INS1-3HA oocysts ampliﬁed in mice from
round two. WT, wild type. HA, INS1-3HA transgenic parasites. The product 59 Ins is speciﬁc for the 59 CRISPR targeting site of INS1-3HA. The product 39 Ins
is speciﬁc for the 39 CRISPR targeting site of INS1-3HA. Control, product is speciﬁc to the INS3 locus. Primers are deﬁned in Table S1. (F) Diagram of the
INS1-GFP-tagged locus in stable transgenic parasites. C. parvum was cotransfected with the INS1-GFP-Nluc-P2A-neo tagging plasmid and CRISPR/Cas9
plasmid containing an INS1 gRNA speciﬁc to the INS1 locus. (G) Relative luminescence per milligram of feces from transgenic C. parvum oocysts. Each data
point represents a single pellet, and each connecting line represents an individual NSG mouse infected with INS1-GFP parasites from round two. (H) The
number of oocysts per milligram of feces was measured by qPCR. Each data point represents a single pellet, and each connecting line represents an
individual NSG mouse infected with INS1-GFP parasites from round two. (I) PCR analysis of INS1-GFP oocysts ampliﬁed in mice from round two. WT, wild
type. GFP, INS1-GFP transgenic parasites. The product 59 Ins is speciﬁc for the 59 CRISPR targeting site of INS1-GFP. The product 39 Ins is speciﬁc for the 39
CRISPR targeting site of INS1-GFP. Control, product is speciﬁc to the INS3 locus. Primers are deﬁned in Table S1.

amplify the INS1-GFP transgenic parasites. In the ﬁrst round of infection in Ifngr12/2
mice, all of the animals succumbed by day 15, indicating the tagged line was not attenuated (Fig. S1). In the second round of ampliﬁcation in NSG mice, luminescence and
oocyst numbers measured from infected mouse feces increased on 6 dpi and remained
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FIG 3 Transcription and expression of C. parvum INS1 in vitro. (A) Relative transcription level of the INS1 gene (cgd1_1680) at speciﬁed
times postinfection, as determined by reverse transcription-quantitative PCR. HCT-8 cells were infected with C. parvum oocysts and cultured
for speciﬁc time points, and RNA was collected from three wells per time point. Gene expression proﬁles are from two separate
experiments with different time points. Data from the Cryptosporidium 18S rRNA gene were used in data normalization. Values are plotted
as the means 6 standard deviations (SD). (B) Immunoﬂuorescence staining of transgenic INS1-3HA parasites. HCT-8 cells were infected
with INS1-3HA oocysts. After 48 hpi, coverslips were ﬁxed and stained with rat anti-HA followed by goat anti-rat IgG Alexa Fluor 488,
rabbit pan-Cp followed by goat anti-rabbit IgG Alexa Fluor 568, and Hoechst for nuclear staining. Scale bars, 2 m m. (C)
Immunoﬂuorescence staining of INS1-GFP parasites. HCT-8 cells were infected with INS1-GFP oocysts. After 48 hpi, coverslips were ﬁxed
and stained with rabbit anti-GFP followed by goat anti-rabbit IgG Alexa Fluor 488, rat pan-Cp followed by goat anti-rat IgG Alexa Fluor
568, and Hoechst for nuclear staining. Scale bars, 2 m m.

elevated 1 month (Fig. 2G and H). PCR analysis conﬁrmed that the INS1-GFP strain had
correctly inserted into the INS1 locus (Fig. 2F and I). Fecal pellets were collected every
day from 12 to 30 dpi for puriﬁcation of transgenic parasites.
INS1 is expressed in macrogamonts. To examine the expression of INS1 during
intracellular development of C. parvum in vitro, we infected HCT-8 cells with wildtype oocysts and tested expression by reverse transcription-quantitative PCR (RTqPCR) at different time points. We used two slightly different sets of RNA samples
designed to cover the time range of the development of asexual and sexual stages,
as described previously (8). The INS1 gene showed no transcription before 30 h postinfection (hpi) but was upregulated at 36 hpi and reached the highest level at 48 hpi
before declining at 72 hpi (Fig. 3A). The sexual stages of C. parvum ﬁrst appear ;36
hpi (7, 8), and the positive signal for INS1 at this time point indicates that INS1 was
expressed in either macrogamonts or microgamonts. To visualize the stage-speciﬁc
expression and localization of INS1, we performed immunoﬂuorescence assays
(IFA) using INS1-3HA and INS1-GFP transgenic parasites. Neither the anti-HA antibody nor anti-GFP antibody detected any staining above background in asexual
stages of C. parvum, consistent with the very low level of transcription of INS1 during these stages. Instead, INS1 was only detected in the macrogamont stage, where
it appeared as punctate staining, while microgamonts remained negative (Fig. 3B
and C).
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FIG 4 Expression of INS1 in different life cycle stages of C. parvum. (A) Immunoﬂuorescence staining of
macrogamont-speciﬁc MAb 4D8 in INS1-GFP parasites. HCT-8 cells were infected with INS1-GFP oocysts. After 48 hpi,
coverslips were ﬁxed and stained with mouse MAb 4D8 followed by goat anti-mouse IgM Alexa Fluor 488, rabbit antiGFP followed by goat anti-rabbit IgG Alexa Fluor 568, rat pan-Cp followed by goat anti-rat IgG Alexa Fluor 647, and
Hoechst for nuclear staining. Scale bars, 2 m m. (B) Immunoﬂuorescence staining of OW50 in INS1-GFP parasites.
Arrowheads indicate staining of OW50-positive vesicles that were in close proximity to INS1. HCT-8 cells were infected
with INS1-GFP oocysts. After 48 hpi, coverslips were ﬁxed and stained with mouse MAb OW50 followed by goat antimouse IgG Alexa Fluor 488, rabbit anti-GFP followed by goat anti-rabbit IgG Alexa Fluor 568, rat pan-Cp followed by
goat anti-rat IgG Alexa Fluor 647, and Hoechst for nuclear staining. Scale bars, 2 m m. (C) Transmission electron
micrographs of macrogamont of INS1-GFP parasites. HCT-8 cells were infected with INS1-GFP oocysts. After 48 hpi,
cells were ﬁxed and stained with rabbit anti-GFP followed by 18-nm colloidal gold goat anti-rabbit IgG. Two images
on the right are enlarged sections of the image on the left, as indicated by the dotted lines. N, nucleus. Scale
bars, 200 nm.

Only a limited number of stage-speciﬁc proteins have been characterized in C. parvum, therefore we investigated two antibodies that have been previously shown to
detect proteins that are expressed in macrogamonts. The punctate structures
stained positively for INS1 did not colocalize with monoclonal antibody (MAb) 4D8,
which recognizes a prominent ﬁlament structure of macrogamonts (10) (Fig. 4A). We
also examined costaining with MAb OW50, which stains cytoplasmic inclusions
called wall-forming bodies that are released to form the oocyst wall (28). INS1 was in
clusters distinct from those of OW50; however, these were often in close proximity to
each other (Fig. 4B). To explore the ultrastructural localization of INS1, INS1-GFP
transgenic parasites were examined by immunoelectron microscopy. INS1 was
located in small vesicles within macrogamonts, and these positive compartments
were often in proximity to large electron-dense vesicles (Fig. 4C). Based on its timing
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of expression and localization, these ﬁndings suggest that INS1 plays some role in
the development of macrogamonts.
Decreased oocyst shedding in Dins1 parasites. To investigate INS1 function in C.
parvum, we generated INS1 knockout (Dins1) parasites using CRISPR/Cas9. The INS1
gene was replaced with an mCherry expression cassette driven by the C. parvum actin
promoter in a construct that also contained the Nluc-P2A-neoR selection marker
described above (Fig. 5A). To ensure complete removal of the INS1 gene, we used two
sgRNA sequences to degenerate double-stranded DNA breaks that ﬂank the gene
(Fig. 5A). Sporozoites were electroporated with the INS1-mCh-Nluc-P2A-neo-INS1 plasmid and a CRISPR/Cas9 plasmid containing the two INS1 sgRNAs (Fig. 5A). Transfected
sporozoites were gavaged into a group of Ifngr12/2 mice treated with 16 g/liter paromomycin in the drinking water. Unlike the tagged lines described above, the knockout
line was attenuated, and none of the Ifngr12/2 mice succumbed over a 30-day period
(Fig. S1). Moreover, the peak leak level of oocyst shedding by the knockout line was
3.5-fold lower than that of the GFP-tagged line at 9 dpi (Fig. S1). After 13 dpi, the feces
containing the Dins1 oocysts were collected and gavaged into a group of immunocompromised mice. For this second-round infection, we were interested in conﬁrming the
attenuation of this line, so we used Ifng2/2 (GKO) mice, which, like Ifngr12/2 mice, are
highly sensitive to C. parvum infection (Fig. 5C). PCR analysis conﬁrmed that oocysts
shed by GKO mice were Dins1 parasites based on correct 59 and 39 ﬂanking sequences
created by the loss of the INS1 gene and insertion of the mCherry expression cassette
in its place (Fig. 5D). Additionally, primers to the open reading frame of INS1 failed to
amplify a product from the knockout line, although they easily detected the expected
fragments from wild-type parasites (Fig. 5D).
We then tracked the expansion of the Dins1 parasites by luciferase measurements
and oocyst shedding in the feces in the second round of mice. Both luminescence values and oocyst shedding increased at 6 dpi and reached the peak at 12 dpi (Fig. 6A).
Moreover, all mice infected by Dins1 parasites survived the infection and continued to
shed oocysts for as long as 1 month, the longest time point we tracked (Fig. 6B).
INS1 requires active protease activity for function. We further tested whether
INS1 requires its protease activity for function. INS1 contains the active-site HLIEH that
is a conserved motif in M16 metalloproteases. We used CRISPR/Cas9 genome editing
to alter the INS1 active site from HLIEH to AAAAA while also adding a C-terminal 3HA
tag (Fig. 5B). The replacement of the endogenous locus with this active-site mutant
template (INS1m) was guided by two sgRNA sequences located in the N terminus and
39-untranslated region (UTR) of the gene (Fig. 5B). Sporozoites were electroporated
with the INS1(mu)-3HA-Nluc-P2A-neo plasmid, and a CRISPR/Cas9 plasmid containing
two INS1 gRNAs and oocysts were ampliﬁed as before. Similar to the Dins1 knockout,
this active-site mutant line was attenuated, and none of the Ifngr12/2 mice succumbed
over a 30-day period (Fig. S1). Moreover, the peak leak level of oocyst shedding by the
mutant line occurred much later, at day 18, and was 26-fold lower than that of the
GFP-tagged line that peaked at day 13 (Fig. S1). To conﬁrm this attenuation, we used
GKO mice for the second round of infection. PCR analysis demonstrated that oocysts
shed by GKO mice contained the correct 59 and 39 insertions of the repair template
integrated into the INS1 locus (Fig. 5E). Sanger DNA sequencing of PCR products ampliﬁed from INS1m parasites conﬁrmed the replacement of the wild-type copy with the
mutated active site in oocysts recovered from the GKO mice (Fig. 5F). The INS1m activesite mutants grew with slower kinetics than wild-type parasites, and all infected mice
survived infection for as long as 1 month, similar to the Dins1 parasites described
above (Fig. 6C and D).
Inhibition of macrogamont maturation in Dins1 and INS1m parasites in vitro. To
test the growth abilities of the knockout and active-site mutants in vitro, we infected
HCT-8 cells with 104 oocysts of each of the mutant versus wild-type parasites and
returned them to culture to allow development. After 48 hpi, we ﬁxed cells and labeled
them with MAb 4D8 to detect macrogamonts as well as pan-Cp antibody to detect all
stages (Fig. 6E). Life cycle stages were then deﬁned on the following bases: meronts
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FIG 5 Selection of Dins1 parasites and INS1m transgenic parasites in immunocompromised mice. (A) Diagram of the strategy to construct Dins1
transgenic parasites. Construct was designed to replace the INS1 locus with an mCherry and Nluc-P2A-NeoR cassette. The top line shows the

(Continued on next page)
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DISCUSSION
The C. parvum genome contains an expanded family of 22 M16 metalloproteases,
the majority of which have unknown functions. Here, we focused on INS1, which is a
clan M16A metalloprotease most similar to human insulinase. INS1 contains a signal
peptide and an active domain containing the catalytic site HXXEH followed by several
inactive domains. Unlike previously described INS proteins that are expressed early in
development in C. parvum, INS1 was expressed exclusively in macrogamonts, where it
localized to small vesicular structures in the cytosol. Deletion of INS1, or replacement
with an active-site mutant, resulted in reduced formation of macrogametocytes in vitro
and lower oocyst shedding in vivo. Our studies reveal that INS1 likely participates in
macrogamont formation, and in its absence the parasite forms fewer oocysts in vivo
and is attenuated in immunocompromised mice.
Metalloproteases are widespread in biology and have been classiﬁed into 16 clans
that are summarized in the MEROPS database (https://www.ebi.ac.uk/merops/). M16
metalloproteases are characterized by the presence of a zinc-binding motif consisting
of the sequence HXXEH (20). M16A and M16C family members contain four domains,
only one of which contains the active catalytic site (20). The best known M16 protease
is human insulinase, which cleaves a variety of small peptides in different types of cells,
consistent with the multiple roles of this enzyme (29). Apicomplexan parasites contain
numerous M16 metalloproteases, although their roles have only partially been investigated. Two M16C proteases have been described in Plasmodium falciparum. Falcilysin
is involved in hemoglobin degradation and processing of the apicoplast import transit
peptides (23, 24), an activity that is also catalyzed by P. falciparum SPP (30).
Toxoplasma gondii contains 11 M16 orthologues, and several M16A enzymes found in
secretory compartments have been previously studied (20). Toxolysin 1 is found in
rhoptries (21), while toxolysin 4 is found in micronemes (22). Both proteases are themselves processed during maturation, but their substrates and the roles these proteases
play in their respective secretory compartments are undeﬁned. Toxolysin 4 is refractory
to gene disruption (22), while the loss of toxolysin 1 has no effect on growth in vitro or

FIG 5 Legend (Continued)
targeting construct, the middle line the genomic locus, and the bottom line the successfully targeted transgenic locus. P2A, split peptide; INS1
gRNA, site of guide RNA homology. (B) Diagram of the strategy to construct INS1m active-site mutants. Construct was designed to make an INS1
point mutation in which the active site HLIEH was mutated to AAAAA and added a 3HA tag and Nluc-P2A-NeoR cassette at the C terminus of
INS1 (cgd1_1680). The top line shows the targeting construct, the middle line the genomic locus, and the bottom line the successfully targeted
transgenic locus. P2A, split peptide; INS1 gRNA, site of guide RNA homology. (C) Selection strategy for obtaining Dins1 or INS1m transgenic
parasites. Transfected sporozoites were gavaged into Ifngr12/2 mice treated with 16 g/liter paromomycin in drinking water. A second round of
selection was conducted in GKO mice. Each mouse in round two was gavaged with a fecal slurry containing 2  104 oocysts collected at 18 dpi of
the ﬁrst round of selection. (D) PCR analysis of Dins1 oocysts obtained from the second round of ampliﬁcation. WT, wild type. KO, Dins1 parasite.
The product 59 Ins is speciﬁc for the 59 CRISPR targeting site of the Dins1 parasite. The product 39 Ins is speciﬁc for the 39 CRISPR targeting site of
Dins1 parasite. The product ORF1 detects a 2,703-bp fragment of the INS1 open reading frame. The product ORF2 detects a 468-bp fragment of the
INS1 open reading frame. (E) PCR analysis of INS1m oocysts obtained from the second round of ampliﬁcation. WT, wild type. mu, INS1m parasite. The
product 59 Ins is speciﬁc for the 59 CRISPR targeting site of INS1m. The product 39 Ins is speciﬁc for the 39 CRISPR targeting site of INS1m. Control,
product is speciﬁc to the INS3 locus. (F) Sequence electropherogram of PCR products from native INS1 (top) and active-site mutant INS1m (bottom)
transgenic parasites. Native, the amino acid and nucleotide sequence of the active site in wild-type INS1 parasite. INS1m, the amino acid and
nucleotide sequence of the active site in INS1m parasite.
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were classiﬁed by one to eight nuclei but no 4D8 labeling, macrogamonts were classiﬁed by a single nucleus and were positive 4D8 labeling, and microgamonts were classiﬁed as having 16 nuclei but no 4D8 labeling. Wild-type parasite cultures showed 55%
of parasites were meronts, 38% of parasites were macrogamonts, and 7% of parasites
were microgamonts at 48 hpi. In contrast, Dins1 cultures showed signiﬁcantly fewer
macrogamonts (24%) with an increase in the proportion of meronts (71%) (Fig. 6F).
Similarly, HCT-8 cultures infected with the active-site INS1m mutant parasites showed
signiﬁcantly fewer macrogamonts (28%) with an increase in the proportion of meronts
(68%) (Fig. 6F). Collectively, these ﬁndings indicate that INS1 functions to facilitate
macrogamont development, and in its absence, oocyst shedding is reduced in immunocompromised mice.

FIG 6 Inﬂuence of Dins1 parasites and INS1m parasites on development of C. parvum in vivo and in vitro. (A) Relative
luminescence of C. parvum per milligram of feces. Each red box represents a single pellet, and each connecting line represents
an individual GKO mouse infected with Dins1 parasites from the second round of ampliﬁcation. (B) The number of oocysts per
milligram of feces was measured by qPCR. Each red dot represents a single pellet, and each connecting line represents an
individual GKO mouse infected with Dins1 parasites from the second round of ampliﬁcation. (C) Relative luminescence of C.
parvum per milligram of feces. Each blue box represents a single pellet, and each connecting line represents an individual GKO

(Continued on next page)
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virulence in vivo (21). Toxolysin 3, encoded by TGME49_257010, is most similar to INS1
by sequence homology. Toxolysin 3 is annotated as a sporozoite development protein
(https://toxodb.org/toxo/app), as it is highly expressed in unsporulated and sporulated
oocysts (31). In contrast, INS1 is expressed exclusively in macrogamonts, indicating
that these M16 metalloproteases have different biological roles.
Of the 22 M16 metalloproteases encoded by the C. parvum genome, 18 of them
belong to the M16A family, and several of these have previously been studied, including INS5, INS15, and INS20-19. INS15 and INS20-19 contain signal peptides, suggesting
they are in the secretory pathway, while INS5 does not have a predicted signal peptide
(25–27). INS20-19 is expressed in sporozoites and localized to an apical compartment
(25), while INS15 is expressed in a middle-anterior compartment in sporozoites and
merozoites (26). In contrast, INS5 is expressed at lower levels in sporozoites and
increases to a peak at 36 to 48 hpi (27). INS5 is present in a punctate pattern in sporozoites and during merogony (27). Antibodies to these proteins have been shown to inhibit parasite invasion in vitro (25–27), suggesting they play some role in processing or
maturation of substrates involved in host cell recognition. Their similar expression pattern during the life cycle, secretory nature, and ability of antibodies against them to
partially neutralize infection suggests that the above-mentioned paralogous INS proteins play partially redundant roles in interacting with the host cell. INS1 is a classic
M16A protease containing a signal peptide and an HLIEH active motif in the N-terminal
domain followed by three domains that lack this catalytic motif. INS1 has closely
related orthologues in other Cryptosporidium spp. (32), suggesting it has a conserved
function. However, unlike the INS proteins mentioned above, INS1 is not expressed in
sporozoites or merozoites and, hence, is unlikely to function in interactions with the
host cell during invasion. The phylogenetic analysis of INS genes in C. parvum identiﬁed several genes that are closely related to INS1. These include INS3 (encoded by
cgd2_920), which is also more highly expressed in macrogamonts (7), although it does
not contain a signal peptide, suggesting that it has a different role than INS1. Likewise,
the related protein INS4 (encoded by cgd2_930), which is expressed much earlier at 24
hpi (7), also lacks a signal peptide, suggesting it has a different role than INS1.
INS1 was not detected in sporozoites or during merogony, but expression was
strongly upregulated at 36 to 48 hpi, when the sexual stages are formed (8). Consistent
with this pattern, previous studies have shown that INS1 and INS3 are highly expressed
in macrogamonts in vivo and in in vitro culture (7). Tagging with the HA epitope or a
GFP fusion indicated that INS1 is expressed exclusively in macrogamonts, where it is
localized to small vesicular structures in the cytosol. INS1 was not colocalized with 4D8
antibody, which recognizes a unique striated ﬁber in macrogamonts (10). Additionally,
INS1 only partially colocalized with OW50, which recognizes large punctate vesicles in
the cytosol of macrogamonts and the wall in mature oocysts (12). When examined by
immunoelectron microscopy, INS1 was found in small vesicular structures that were

FIG 6 Legend (Continued)
mouse infected with INS1m parasites from the second round of ampliﬁcation. (D) The number of oocysts per milligram of feces
was measured by qPCR. Each blue dot represents a single pellet, and each connecting line represents an individual GKO mouse
infected with INS1m parasites from the second round of ampliﬁcation. (E) Outline of the experimental protocol to analyze growth
of WT or Dins1 or INS1m parasites in HCT-8 cells. C. parvum WT or Dins1 or INS1m parasites were used to infect HCT-8 cells. After
48 hpi, wells were washed, ﬁxed, and labeled with different antibodies. For WT parasites, coverslips were stained with mouse
MAb 4D8 that detects macrogamonts followed by goat anti-mouse IgM Alexa Fluor 488, rabbit pan-Cp followed by goat antirabbit IgG Alexa Fluor 568, and Hoechst for nuclear staining. For Dins1 parasites, coverslips were stained with mouse 4D8
followed by goat anti-mouse IgM Alexa Fluor 488, rat anti-mCherry followed by goat anti-rat IgG Alexa Fluor 568, rabbit pan-Cp
followed by goat anti-rabbit IgG Alexa Fluor 647, and Hoechst for nuclear staining. For INS1m parasites, coverslips were stained
with mouse 4D8 followed by goat anti-mouse IgM Alexa Fluor 488, rabbit pan-Cp followed by goat anti-rabbit IgG Alexa Fluor
568, rat anti-HA followed by goat anti-rat IgG Alexa Fluor 647, and Hoechst for nuclear staining. (F) Quantiﬁcation of life cycle
stages of wild-type, Dins1 (left), or INS1m (right) parasites. Meronts were identiﬁed by their content of 1 to 8 nuclei;
macrogamonts were identiﬁed by labeling with MAb 4D8; microgamonts were identiﬁed by many small nuclei (;16 nuclei). Each
time point represents the average from three biological replicates. The number of parasites was counted from 50 ﬁelds of view
with a 100 oil objective. Values are plotted as the means 6 SD. Statistical analysis was performed using unpaired Student's t
test for two-sample comparison (*, P , 0.05; **, P , 0.01).
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often adjacent to large electron-dense vesicles. These large vesicles resemble wallforming bodies, which are large cytoplasmic vesicles that contain proteins involved in
the formation of the oocyst wall (33). Attempts to label OW50, a component of wallforming bodies and the oocyst wall, in combination with INS1 by immunoelectron microscopy were not successful. Nonetheless, the proximity of small vesicles containing
INS1 to the larger vesicles suggests that INS1 is involved in the processing or trafﬁcking
of constituents of the wall-forming body vesicles and that disruption of this process
impairs macrogamont maturation and subsequent oocyst formation. Like other insulinase enzymes (19), INS1 is predicted to have a small folded barrel containing the active
site that is only capable of accommodating small peptides ranging from 3 to 6 kDa. As
such, INS1 is likely to process small peptides, possibly resulting from trimming of secretory proteins by other peptidases in the secretory pathway.
The deletion of INS1, or replacement with the INS1m active-site mutant, did not
affect asexual replication in vitro or completely block development, indicating that
INS1 is not essential for growth. Instead, the loss of INS1 resulted in the reduced formation of macrogamonts in vitro and lower oocyst shedding in vivo. In human insulinase,
replacement of E111 in the HXXEH active site with Q111 inactivates catalysis (34, 35).
Similarly, the insulinase homologue Iph1 in yeast loses catalytic activity when the E71
active site is changed to D71 (36). Although we have not formally demonstrated that
the INS1m enzyme has lost catalytic activity, the complete replacement of the HXXEH
site with AAAAA is consistent with that interpretation. Hence, the similar phenotypes
of the Dins1 strain and the INS1m active-site mutants suggest that the observed phenotype of the knockout is due to the loss of catalytic activity. We also observed that the
defect in the INS1m active site was approximately 2 times more severe in terms of
reduced oocyst shedding than the complete deletion, suggesting the expression of
an inactive enzyme has a dominant-negative effect that is greater than the loss
of the enzyme. Both the Dins1 and the INS1m active-site mutants were less virulent in
Ifngr12/2 and GKO mice, and reduced oocyst shedding was associated with survival
beyond 12 days, when mice infected with epitope-tagged or GFP-tagged parasites succumbed to infection. The lower virulence of the INS1 mutants is likely an indirect consequence of reduced macrogamonts, fewer oocysts, and possibly fewer thin-walled
oocysts that are thought to result in reinfection, since pathology caused by the infection is normally associated with multiple rounds of merogony.
Our studies reveal that INS1 participates in macrogamont formation or maturation
and that the catalytic function of INS1 is necessary for the optimal formation of
oocysts. Cryptosporidium oocysts are comprised of an inner layer of glycoproteins,
called oocyst wall proteins (OWPs), that are rich in cysteine and histidine (37) in addition to an outer acid-fast lipid layer (38). The process by which these components are
synthesized, exported, and assembled into layers in the wall is largely unknown. In
addition to providing insight into the development of macrogamonts, further study of
INS1, and related peptidases, may reveal further insights into the process of oocyst
wall formation.
MATERIALS AND METHODS
Animal studies. Animal studies on mice were approved by the Institutional Animal Studies
Committee (School of Medicine, Washington University in St. Louis). The Ifngr12/2 mice (003288;
Jackson Laboratories), Ifng2/2 mice (referred to as GKO) (002287; Jackson Laboratories), and Nod scid
gamma mice (referred to as NSG) (005557; Jackson Laboratories) were bred in-house at Washington
University School of Medicine and were separated by sex after weaning. Ifngr12/2 and GKO mice raised
in our facility are highly susceptible to the strain of C. parvum used here, and they shed high numbers of
oocysts and routinely die within 10 to 12 dpi. As such, they are used to amplify transgenic strains following initial transfection of sporozoites. In contrast, NSG mice are more resistant and can be used for
prolonged oocyst shedding, which occurs are lower peak levels. Mice were reared in a speciﬁc-pathogen-free facility on a 12-h:12-h light-dark cycle and water ad libitum. For selection and ampliﬁcation of
transgenic C. parvum parasites, 8- to 12-week-old mice were used and water was replaced with ﬁltered
tap water containing 16 g/liter paromomycin sulfate salt (Sigma). During the course of infection, animals
that lost more than 20% of their body weight or became nonambulatory were humanely euthanized.
March/April 2021 Volume 12 Issue 2 e03405-20

mbio.asm.org

12

Downloaded from https://journals.asm.org/journal/mbio on 24 February 2022 by 75.132.44.168.

®

Xu et al.

Phylogenetic analysis. The amino acid sequences of INS in Cryptosporidium parvum were extracted
from CryptoDB (https://cryptodb.org/cryptodb/app), and the human insulinase was extracted from
UniProt (https://www.uniprot.org). The phylogenetic tree was constructed based on these sequences.
MUSCLE was used to align the concatenated sequences. Phylogenetic trees based on maximum likelihood were constructed with 1,000 replications for bootstrapping.
Primers. All primers were synthesized by Integrated DNA Technologies and are listed in Table S1 in
the supplemental material.
Oocyst preparation and excystation. Cryptosporidium parvum oocysts were obtained from the
Witola laboratory (University of Illinois at Urbana-Champaign). The C. parvum isolate (AUCP-1) was maintained by repeated passage in male Holstein calves and puriﬁed from fecal material, as described previously (39). Puriﬁed oocysts were stored at 4°C in 50 mM Tris-10 mM EDTA (pH 7.2) for up to 6 months
before use. Before infection, 1  108 puriﬁed oocysts were diluted into 1 ml of Dulbecco’s phosphatebuffered saline (DPBS; Corning Cellgro) and treated with 3 ml of 40% bleach (containing 8.25% sodium
hypochlorite) for 10 min on ice. Oocysts were then washed 4 times in DPBS containing 1% (wt/vol) bovine serum albumin (BSA; Sigma) and resuspended in 1 ml DPBS with 1% BSA. For some experiments,
oocysts were excysted prior to infection by incubating the oocysts with 0.75% (wt/vol) sodium taurocholate (Sigma) at 37°C for 60 min.
HCT-8 cell culture. Human ileocecal adenocarcinoma cells (HCT-8 cells; ATCC CCL-244) were cultured in RPMI 1640 medium (ATCC modiﬁcation; Gibco) supplemented with 10% fetal bovine serum.
The HCT-8 cells were determined to be mycoplasma negative using the e-Myco plus kit (Intron
Biotechnology).
Gene expression analysis. HCT-8 cells were grown on 6-well culture plates and incubated 24 h
before infection. Monolayers were infected with excysted sporozoites and washed twice with DPBS at 2
hpi, and fresh HCT-8 medium then was added. RNA was collected from three wells per time point in RLT
buffer (Qiagen) plus 1% b -mercaptoethanol, homogenized using a QIAshredder column (Qiagen), and
then stored at 280°C until further processing. RNA was extracted using the RNeasy minikit (Qiagen),
treated with the DNA-free DNA removal kit (Thermo Fisher Scientiﬁc), and converted to cDNA using the
SuperScript VILO cDNA synthesis kit (Thermo Fisher Scientiﬁc). Reverse transcription quantitative PCR
(RT-qPCR) was performed using a QuantStudio 3 real-time PCR system (Thermo Fisher Scientiﬁc) with
SYBR green JumpStart Taq ReadyMix (Sigma) using primers listed in Table S1. The following conditions
were used for RT-qPCR: priming at 95°C for 2 min, followed by 40 cycles of denaturing at 95°C for 10 s,
annealing at 60°C for 20 s, and extension at 72°C for 30 s, followed by a melt curve analysis to detect
nonspeciﬁc ampliﬁcation. Relative gene expression was calculated with the DDCT method (40) using C.
parvum 18S rRNA as the reference gene.
Gene tagging using CRISPR/Cas9. To provide a single guide RNA (sgRNA) plasmid for INS1, the
plasmid pACT1:Cas9-GFP, U6:sgINS1 was generated by replacing the TK sgRNA in pACT1:Cas9-GFP, U6:
sgTK plasmid (12) with an sgRNA matching a region 158 bp before the stop codon in the INS1 gene
(cgd1_1680), using Q5 site-directed mutagenesis (New England Biosciences). The INS1 sgRNA was
designed using the eukaryotic pathogen CRISPR guide RNA/DNA design tool (http://grna.ctegd.uga
.edu). To generate a tagging plasmid, a portion of the INS1 C terminus (253 bp) with the mutant protospacer adjacent motif (PAM) and INS1 39UTR (117 bp) was ampliﬁed from C. parvum genome DNA. The
triple hemagglutinin (3HA) epitope tag was ampliﬁed from pTUB1:YFP-mAID-3HA, DHFR-TS:HXGPRT
(41). The previously described Nluc-P2A-neoR reporter including the pUC19 backbone was ampliﬁed
from TK-GFP-Nluc-P2A-neo-TK plasmid (12). The tagging plasmid pINS1-3HA-Nluc-P2A-neo was then
generated by Gibson assembly of the components listed above. To generate a C-terminal tag with a
green ﬂuorescent protein (GFP) tag, the plasmid pINS1-GFP-Nluc-P2A-neo was constructed by swapping
the 3HA with GFP from TK-GFP-Nluc-P2A-neo-TK plasmid using Gibson assembly of PCR-ampliﬁed
fragments.
Gene deletion using CRISPR/Cas9. To provide a plasmid for gene deletion, a second sgRNA, U6:
sgINS1(2), was inserted in the plasmid pACT1:Cas9-GFP, U6:sgINS1 to generate the plasmid pACT1:Cas9GFP, dual, U6:sgINS1-KO. This plasmid contains two sgRNAs that ﬂank the gene, one located at the C terminus of INS1, 158 bp before the stop codon, and one located at the N terminus of INS1, 55 bp after the
promoter. The targeting plasmid pINS1-mCh-Nluc-P2A-neo-INS1 was made by replacing the UPRT homologous ﬂanks with INS1 homologous ﬂanks (770 bp upstream and 852 bp downstream of cgd1_1680)
from UPRT-mCh-Nluc-P2A-neo-UPRT (12) using Gibson assembly of PCR-ampliﬁed fragments.
Generating point mutations using CRISPR/Cas9. To generate an active-site mutant of INS1, the
plasmid pACT1:Cas9-GFP, dual, U6:sgINS1-mu was generated by inserting two new sgRNAs in the
pACT1:Cas9-GFP, U6:sgTK plasmid. This plasmid contains two sgRNAs that ﬂank the gene, one located at
the N terminus of INS1, 5 bp after the active site, and one is located at the 39UTR of INS1, 3 bp after the
stop codon. To generate the targeting plasmid, a portion of the C terminus INS1 homologous ﬂanks
with ﬂanking regions before the active site (3,081 bp of cgd1_1680) and 117-bp INS1 39UTR was ampliﬁed from C. parvum genome DNA, and PAM sequences were mutated to prevent recutting the repair
DNA. The active site in INS1 HLIEH was then mutated to AAAAA using Q5 site-directed mutagenesis. The
3HA-Nluc-P2A-neoR reporter including the pUC19 backbone was ampliﬁed from INS1-3HA-Nluc-P2A-neo
plasmid. The targeting plasmid pINS1(mu)-3HA-Nluc-P2A-neo was generated by Gibson assembly of the
components listed above.
Transfection of C. parvum sporozoites. Oocysts (1.25  107 per transfection) were excysted as
described above, and sporozoites were pelleted by centrifugation and resuspended in SF buffer (Lonza)
containing 50 m g of tagging or targeting plasmids and 30 m g CRISPR/Cas9 plasmid in a total volume
of 100 m l. The mixtures were then transferred to a 100-m l cuvette (Lonza) and electroporated on an
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AMAXA 4D-Nucleofector system (Lonza) using program EH100. Electroporated sporozoites were transferred to cold DPBS and kept on ice before infecting mice.
Selection and ampliﬁcation of transgenic parasites in immunodeﬁcient mice. Three Infgr12/2
mice were used for the ﬁrst round of transgenic parasite selection. Each mouse was orally gavaged with
200 m l of saturated sodium bicarbonate 5 min prior to infection. Each mouse was then gavaged with
2.5  107 electroporated sporozoites. All mice received drinking water with 16 g/liter paromomycin continuously from the ﬁrst day postinfection (dpi), based on previously published protocols (13). Fecal pellets were collected begin at 9 to 15 dpi, after which animals were euthanized by CO2 asphyxiation
according to the animal protocol guidelines. Fecal pellets were stored at 280°C for qPCR or at 4°C for luciferase assays or for isolating oocysts for subsequent infections.
A second round of ampliﬁcation was performed by orally gavaging 3 to 4 NSG mice (used for isolating tagged strains) or GKO mice (used for amplifying knockout or mutation lines) using a fecal slurry
from round one mice described above. The fecal pellets were transferred to a 1.7-ml microcentrifuge
tube, ground with a pestle, diluted by addition of 1 ml cold DPBS, vortexed for 30 s, and centrifuging at
200 rpm for 10 min to pellet large particulates. The supernatant was then diluted in DPBS to achieve a
concentration of ;2  104 oocysts in 200 m l DPBS and then gavaged into one mouse. Similar to round
one, the mice infected in round two were treated with 16 g/liter paromomycin drinking water for the entirety of the experiment. Fecal pellets for qPCR and luciferase assay were collected every 3 days starting
3 dpi and fecal pellets for puriﬁcation were collected every day starting at 12 dpi and stored at 4°C. For
puriﬁcation, fecal samples from all mice were pooled and oocysts extracted as previously described (42).
Puriﬁed oocysts were stored in PBS at 4°C and used within 6 months of extraction.
Luciferase assay. Luciferase assays were performed with the Nano-Glo Luciferase assay kit
(Promega). Mouse fecal pellets were collected in 1.7-ml microcentrifuge tubes, ground with a pestle,
and then 3-mm glass beads (Fisher Scientiﬁc) and 1 ml fecal lysis buffer (50 mM Tris pH 7.6, 2 mM DTT,
2 mM EDTA pH 8.0, 10% glycerol, 1% Triton X-100 prepared in water) (43) were added to the tube.
Tubes were incubated at 4°C for 30 min, vortexed for 1 min, and then spun at 16,000  g for 1 min to pellet debris. The 100-m l supernatant was added split between two wells of a 96-well white plate (Costar
3610), and then 100 m l of a 25:1 Nano-Glo Luciferase buffer to Nano-Glo Luciferase substrate mix was
added to each well, and the plate was incubated for 3 min at room temperature. Luminescence values
were read on a Cytation 3 cell imaging multi-mode reader (BioTek).
Fecal DNA extraction and quantiﬁcation of oocysts. DNA was extracted from fecal pellets using
the QIAamp PowerFecal DNA kit (Qiagen) according to the manufacturer’s protocols. Oocyst numbers
were quantiﬁed using qPCR with the C. parvum glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
primers (Table S1), as described previously (12). A standard curve for C. parvum genomic DNA was generated by purifying DNA from a known number of oocysts and creating a dilution series. Reactions were
performed on a QuantStudio 3 real-time PCR system (Thermo Fisher) with the ampliﬁcation conditions
as previously described (12).
PCR identiﬁcation of transgenic parasites. To check for the successful insertion of the target
sequence into the INS1 locus, PCR was performed on 1 m l puriﬁed fecal DNA using Q5 Hot Start high-ﬁdelity 2 master mix (New England Biosciences) with primers listed in Table S1 at a ﬁnal concentration
of 500 nM each. PCRs were performed on a Veriti 96-well thermal cycler (Applied Biosystems) with the
following cycling conditions: 98°C for 30 s, followed by 35 cycles of 98°C for 15 s, 60°C for 30 s, and 72°C
for 2 min, with a ﬁnal extension of 72°C for 2 min. PCR products were resolved on 1.0% agarose gel containing GelRed (diluted 1:10,000; Biotium) and imaged on a ChemiDoc MP imaging system (Bio-Rad).
Indirect immunoﬂuorescence microscopy. HCT-8 cells grown on coverslips were infected 24 h
postseeding with 1  105 oocysts per well and then ﬁxed with 4% formaldehyde at speciﬁc time points.
The ﬁxed samples were washed twice with DPBS and then permeabilized and blocked with DPBS containing 1% BSA and 0.1% Triton X-100 (Sigma). Primary antibodies were diluted in blocking buffer for
staining: rat anti-HA was used at 1:500, rabbit anti-GFP was used at 1:1,000, MAb 4D8 (hybridoma supernatant) was used at 1:20, MAb OW50 (10) was used at 1:10, and pan-Cp (rabbit or rat polyclonal antibody) was used at 1:10,000. Cells were incubated with primary antibodies for 60 min at room temperature, washed three times with PBS, and then incubated for 60 min at room temperature in secondary
antibodies conjugated to Alexa Fluor dyes (Thermo Fisher Scientiﬁc) diluted 1:1,000 in blocking buffer.
Nuclear DNA was stained with Hoechst (Thermo Fisher Scientiﬁc) diluted 1:1,000 in blocking buffer for
15 min at room temperature and then mounted with Prolong Diamond antifade mountant (Thermo
Fisher Scientiﬁc). Imaging was performed on a Zeiss Axioskop Mot Plus ﬂuorescence microscope
equipped with a 100, 1.4-numeric-aperture Zeiss Plan Apochromat oil objective lens and an AxioCam
MRm monochrome digital camera. Images were acquired using AxioVision software (Carl Zeiss Inc.) and
manipulated in ImageJ or Photoshop.
Transmission electron microscopy. HCT-8 cells were infected with INS1-GFP parasites for 48 h, and
infected cells then were ﬁxed in freshly prepared mixture of 4% paraformaldehyde and 0.05% glutaraldehyde (Polysciences Inc., Warrington, PA) in 100 mM piperazine-N,N9-bis(2-ethanesulfonic acid) (PIPES)–
0.5 mM MgCl2 buffer (pH 7.2) for 60 min at 4°C. Samples were then embedded in 10% gelatin and inﬁltrated overnight with 2.3 M sucrose–20% polyvinyl pyrrolidone in PIPES–MgCl2 at 4°C. Samples were
trimmed, frozen in liquid nitrogen, and sectioned with a Leica Ultracut UCT7 cryo-ultramicrotome (Leica
Microsystems Inc., Bannockburn, IL). Ultrathin sections of 50 nm were blocked with 5% fetal bovine serum–5% normal goat serum for 30 min and subsequently incubated with rabbit anti-GFP antibody (Life
Technologies Corp., Eugene, OR) for 60 min at room temperature. Following washes in block buffer, sections were incubated with goat anti-rabbit IgG (H1L) conjugated to 18-nm colloidal gold (Jackson
ImmunoResearch Laboratories, Inc., West Grove, PA) for 60 min. Sections were stained with 0.3% uranyl
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acetate–2% methyl cellulose and viewed on a JEOL 1200 EX transmission electron microscope (JEOL
USA Inc., Peabody, MA) equipped with an AMT 8 megapixel digital camera and AMT Image Capture
Engine V602 software (Advanced Microscopy Techniques, Woburn, MA). All labeling experiments were
conducted in parallel with controls omitting the primary antibody. These controls were consistently negative at the concentration of colloidal gold conjugated secondary antibodies used in these studies.
Quantiﬁcation and statistical analysis. All statistical analyses were performed in GraphPad Prism 8
(GraphPad Software) unless otherwise speciﬁed. When comparing the means of two groups at the same
time point, we used an unpaired t test. For statistical analysis, P values of #0.05 were considered
signiﬁcant.
Data availability. All of the data are found in the manuscript or supplemental material.
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FIG S1, DOCX ﬁle, 0.4 MB.
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